PFM Health Sciences’s THORATEC CORPORATION THOR Stock Holding History

PFM Health Sciences’s Portfolio THOR Stock Details THOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-432,577	Closed	-$27.4M	–	94
2015 Q3	$27.4M	Sell	432,577 -297,497	-41%	-$17.7M	0.77%	44
2015 Q2	$32.5M	Buy	730,074 +164,275	+29%	+$7.19M	0.82%	44
2015 Q1	$23.7M	Buy	565,799 +98,888	+21%	+$3.77M	0.65%	54
2014 Q4	$15.2M	Buy	+466,911	New	+$13.6M	0.35%	68

Other funds holding THOR

MCM

Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

PFM Health Sciences's THOR Position: Q4 2015 in Review

PFM Health Sciences sold out of THORATEC CORPORATION (THOR) in Q4 2015, closing a stake of 432,577 shares — an estimated $27.4M sold.

PFM Health Sciences first reported a position in THOR in Q4 2014 and held it in 4 quarters. The position peaked at $32.5M in Q2 2015. 2 funds tracked by Wall St. Rank hold THOR as of Q4 2015.

PFM Health Sciences reported no remaining THORATEC CORPORATION position as of Q4 2015 after selling out during the quarter.
PFM Health Sciences sold 432,577 THORATEC CORPORATION shares in Q4 2015, an estimated $27.4M.
PFM Health Sciences first reported a position in THORATEC CORPORATION in Q4 2014 and held it in 4 quarters.
PFM Health Sciences's THORATEC CORPORATION position peaked at $32.5M in Q2 2015.
2 funds tracked by Wall St. Rank held THORATEC CORPORATION as of Q4 2015.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.